As of 2025-07-21, the Relative Valuation of Enzon Pharmaceuticals Inc (ENZN) is 0.04 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 USD, the upside of Enzon Pharmaceuticals Inc based on Relative Valuation is -48.4%.
The range of the Relative Valuation is 0.04 - 0.05 USD.
| Range | Selected | |
| Trailing P/E multiples | 3.4x - 4.9x | 4.1x |
| Forward P/E multiples | 2.6x - 3.8x | 3.2x |
| Fair Price | 0.04 - 0.05 | 0.04 |
| Upside | -58.6% - -38.3% | -48.4% |
| Date | P/E |
| 2025-07-16 | 8.62 |
| 2025-07-15 | 10.44 |
| 2025-07-14 | 9.54 |
| 2025-07-11 | 9.17 |
| 2025-07-10 | 9.30 |
| 2025-07-09 | 9.54 |
| 2025-07-08 | 10.49 |
| 2025-07-07 | 9.92 |
| 2025-07-03 | 10.96 |
| 2025-07-02 | 10.75 |
| 2025-07-01 | 11.18 |
| 2025-06-30 | 12.11 |
| 2025-06-27 | 11.12 |
| 2025-06-26 | 9.54 |
| 2025-06-25 | 8.95 |
| 2025-06-24 | 8.09 |
| 2025-06-23 | 5.73 |
| 2025-06-20 | 7.73 |
| 2025-06-18 | 7.74 |
| 2025-06-17 | 8.03 |
| 2025-06-13 | 7.82 |
| 2025-06-11 | 8.36 |
| 2025-06-10 | 8.05 |
| 2025-06-09 | 8.05 |
| 2025-06-06 | 8.13 |
| 2025-06-05 | 8.68 |
| 2025-06-04 | 8.20 |
| 2025-05-30 | 8.20 |
| 2025-05-28 | 8.60 |
| 2025-05-27 | 8.58 |
| 2025-05-23 | 7.94 |
| 2025-05-22 | 7.96 |
| 2025-05-21 | 7.96 |
| 2025-05-20 | 9.51 |
| 2025-05-19 | 9.53 |
| 2025-05-16 | 8.89 |
| 2025-05-15 | 7.87 |
| 2025-05-14 | 8.16 |
| 2025-05-13 | 8.09 |
| 2025-05-12 | 9.06 |
| 2025-05-09 | 8.99 |
| 2025-05-08 | 9.54 |
| 2025-05-07 | 9.52 |
| 2025-05-06 | 9.52 |
| 2025-05-05 | 9.52 |
| 2025-05-02 | 9.54 |
| 2025-05-01 | 8.16 |
| 2025-04-30 | 8.58 |
| 2025-04-29 | 8.99 |
| 2025-04-25 | 8.58 |